Overview
Myelocystocele is a rare form of closed (skin-covered) spinal dysraphism, classified as a type of neural tube defect. It is characterized by a cystic dilation of the central canal of the spinal cord that herniates through a posterior spina bifida defect, forming a fluid-filled sac covered by skin. Myelocystocele most commonly occurs in the lumbosacral or terminal region of the spine and is sometimes referred to as terminal myelocystocele. The condition is typically detected at birth as a visible skin-covered mass over the lower back. Unlike open neural tube defects such as myelomeningocele, the neural tissue in myelocystocele remains covered by skin, which may reduce the risk of infection but does not eliminate neurological complications. The condition primarily affects the nervous system, the musculoskeletal system, and the urogenital system. Key clinical features include lower limb weakness or motor deficits, neurogenic bladder dysfunction, bowel dysfunction, and tethered spinal cord. Myelocystocele is frequently associated with other congenital anomalies, particularly those involving the genitourinary tract, anorectal malformations, and sacral bony abnormalities. It may occur as part of a broader spectrum of caudal anomalies. Some cases are associated with cloacal exstrophy or the OEIS complex (omphalocele, exstrophy, imperforate anus, spinal defects). Diagnosis is typically made through prenatal ultrasound or postnatal MRI imaging, which reveals the characteristic cystic expansion of the terminal spinal cord. Treatment is primarily surgical, involving neurosurgical repair to untether the spinal cord, drain the cyst, and reconstruct the dural and soft tissue layers. Early surgical intervention is generally recommended to prevent progressive neurological deterioration. Long-term management often requires a multidisciplinary approach including urology, orthopedics, and rehabilitation to address bladder dysfunction, mobility issues, and other associated anomalies. Prognosis varies depending on the severity of the defect and associated malformations, but many patients retain some degree of neurological function given the closed nature of the lesion.
Multifactorial
Caused by a mix of several genes and environmental factors
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Myelocystocele.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Myelocystocele at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Myelocystocele.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Myelocystocele.
Community
No community posts yet. Be the first to share your experience with Myelocystocele.
Start the conversation →Latest news about Myelocystocele
No recent news articles for Myelocystocele.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Myelocystocele
What is Myelocystocele?
Myelocystocele is a rare form of closed (skin-covered) spinal dysraphism, classified as a type of neural tube defect. It is characterized by a cystic dilation of the central canal of the spinal cord that herniates through a posterior spina bifida defect, forming a fluid-filled sac covered by skin. Myelocystocele most commonly occurs in the lumbosacral or terminal region of the spine and is sometimes referred to as terminal myelocystocele. The condition is typically detected at birth as a visible skin-covered mass over the lower back. Unlike open neural tube defects such as myelomeningocele, th
How is Myelocystocele inherited?
Myelocystocele follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Myelocystocele typically begin?
Typical onset of Myelocystocele is neonatal. Age of onset can vary across affected individuals.